CT-2657

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCT-2657
Drug Alias NameCT-2657
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCti Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCti Biopharma Corp
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A